STABILISIERTE ÜBERHALOGENIGEN SÄURELÖSUNGEN

European patent · EP2685832 · In force

Register entry

Publication number: EP2685832
Application number: EP12760461
Kind: European patent with effect for Switzerland and Liechtenstein
Status: In force
Specification: Granted
Filed: Mar 19, 2012
Published: Jan 22, 2014
Granted: May 8, 2019
Protection ends at the latest: Mar 18, 2032
Next annual fee due: Mar 31, 2027
IPC classes: A01N 59/00 (2006.01)
A61K 33/20 (2006.01)
A01P 1/00 (2006.01)
A61P 31/00 (2006.01)
Priority: US 201161454383 P 18.03.2011
US 201161526149 P 22.08.2011
PCT application: PCT/US2012/029650 19.03.2012
PCT publication: WO2012/129161 27.09.2012
Filing language: English
Source: Swissreg

What the Federal Institute of Intellectual Property published about this title, newest first.

Apr 1, 2026
Change
Published in Swissreg on 01.04.2026
Aug 19, 2025
Agent’s address changed
Representative
Stolmár & Partner Intellectual Property GmbH, Bahnhofstrasse 11, 6210 Sursee
Published in Swissreg on 19.08.2025
Apr 1, 2025
Change
Published in Swissreg on 01.04.2025
Apr 2, 2024
Change
Published in Swissreg on 02.04.2024
Apr 1, 2023
Change
Published in Swissreg on 01.04.2023
Aug 28, 2019
Owner
Owner
Realm Therapeutics, Inc., 508 Lapp Road, Malvern, PA 19355, USA → Urgo US, Inc., 3801 Hulen Street, Suite 251, Fort Worth, TX 73107, USA
Published in Swissreg on 28.08.2019
May 8, 2019
Granted
Published in Swissreg on 08.05.2019

3801 Hulen Street, Suite 251, Fort Worth, TX 73107, US

Bahnhofstrasse 11, 6210 Sursee